Fifth AACR-IASLC International Joint Conference: Lung Cancer Translational Science from the Bench to the Clinic

​Jan. 8-11, 2018
Hard Rock Hotel
San Diego, California

Conference Chairs
Charles M. Rudin, Memorial Sloan Kettering Cancer Center, New York, New York
Charles Swanton, The Francis Crick Institute and UCL Cancer Institute, London, England

Conference Cochairs
Tony S.K. Mok, Chinese University of Hong Kong, Shatin, Hong Kong
Lecia V. Sequist, Massachusetts General Hospital Cancer Center, Boston, Massachusetts
Monte M. Winslow, Stanford University School of Medicine, Stanford, California

Under the leadership of Margaret Foti, PhD, MD (h.c.), CEO of the American Association for Cancer Research (AACR), and Fred R. Hirsch, MD, PhD, CEO of the International Association for the Study of Lung Cancer (IASLC), we are thrilled to join in our fifth biennial conference on lung cancer research and treatment. The translational science featured at this conference will include basic research foundation at the bench to patient care in the clinic. This conference has historically joined a diverse group of attendees (physicians, patient advocates, and scientists in basic, translational, and clinical lung cancer research) and provided a venue to discuss recent advances and establish new collaborations. As in our past successful conferences, sessions will range in topics spanning immunotherapy, molecular targets, genetics, drug resistance, clinical trials, patient advocacy, and more. This conference is not only a dynamic collaboration of the AACR and the IASLC, two organizations committed to the study of cancer, but also a dynamic collaboration of the many individuals charged with the study and treatment of this disease.   


Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available